Pudek M R, McIntosh H W
Clin Biochem. 1981 Jun;14(3):142-5. doi: 10.1016/s0009-9120(81)90295-2.
We describe a clinically euthyroid 60-year old woman with a past history of 1311 therapy for treatment of possible toxic nodular goitre. She had an elevated thyroxine level of 188 microgram/L (normal range 50-125 microgram/L) following her therapy, and her TSH was within normal limits at 4.7 mU/L. However her T3 level, as determined by an RIA technique employing charcoal to separate bound and free T3, was not measurable. T3 added to the patient's serum could not be recovered, therefore the presence of an unusual protein capable of binding T3 was suspected. To avoid this interference, T3 analysis was performed on an ethanol extract of the patient's serum and was found to be 17 microgram/L (normal range 0.8-1.8 microgram/L). At this time her thyroid microsomal antibody titre was 1:100,000. A protein, capable of binding more than 70% of the patient's T3, was demonstrated in the gamma globulin fraction by agarose gel electrophoresis. This protein did not bind T4. Scatchard analysis for T3 binding revealed a protein, presumably IGG, with a binding affinity of 2 x 109 L/mole and binding capacity of 50 microgram/L. This case exemplifies the caution that must be taken in interpreting thyroid function tests. When thyroid hormone levels are inappropriate to the clinical status of the patient the presence of circulating antibodies which can bind the thyroid hormones should be considered.
我们描述了一位60岁临床甲状腺功能正常的女性,她曾因可能的毒性结节性甲状腺肿接受过131I治疗。治疗后她的甲状腺素水平升高至188微克/升(正常范围50 - 125微克/升),促甲状腺激素(TSH)在正常范围内,为4.7 mU/L。然而,采用活性炭分离结合型和游离型T3的放射免疫分析(RIA)技术测定,其T3水平无法测出。添加到患者血清中的T3无法回收,因此怀疑存在一种能结合T3的异常蛋白质。为避免这种干扰,对患者血清的乙醇提取物进行T3分析,结果发现为17微克/升(正常范围0.8 - 1.8微克/升)。此时她的甲状腺微粒体抗体滴度为1:100,000。通过琼脂糖凝胶电泳在γ球蛋白组分中证实了一种能结合患者70%以上T3的蛋白质。这种蛋白质不结合T4。对T3结合的Scatchard分析显示一种蛋白质,推测为免疫球蛋白G(IgG),结合亲和力为2×109升/摩尔,结合容量为50微克/升。该病例说明了在解释甲状腺功能检查结果时必须谨慎。当甲状腺激素水平与患者临床状况不符时,应考虑存在可结合甲状腺激素的循环抗体。